tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Leuchten, 6 are a BUY (28.57%), 11 are a HOLD (52.38%), 4 are a SELL (19.05%).
Analyst Michael Leuchten, currently employed at UBS, carries an average stock price target met ratio of 50% that have a potential upside of 11.41% achieved within 207 days.
Michael Leuchten’s has documented 36 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 20-Nov-2024.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 3/23/2020. The price target of $31.06 was fulfilled within 32 days with a profit of $7.17 (30.01%) receiving and performance score of 9.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
1 months ago
(20-Nov-2024)
0/6 (0%)
$75.62 (112.66%)
Sell
1 months 14 days ago
(06-Nov-2024)
1/11 (9.09%)
$82.61 (131.40%)
2587
Buy
$95
$28.42 (42.69%)
$66
4 months 8 days ago
(12-Aug-2024)
6/7 (85.71%)
$12.48 (15.12%)
360
Buy
$85
$18.42 (27.67%)
$80
6 months 20 days ago
(30-May-2024)
4/4 (100%)
$8.23 (10.72%)
390
Buy
$82
$15.42 (23.16%)
$80
7 months 24 days ago
(26-Apr-2024)
4/4 (100%)
$6.83 (9.09%)
296
Which stock is Michael Leuchten is most bullish on?
What Year was the first public recommendation made by Michael Leuchten?
